LO FRANCIS sold $695K of ADPT
LO FRANCIS (Chief People Officer) sold 39,741 shares of Adaptive Biotechnologies Corp (ADPT) at $17.49 ($0.70M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new fact is the officer’s open-market sale amount, share count, and confirmation of a pre-arranged 10b5-1 plan; no new company fundamentals are disclosed.
Market read
A routine 10b5-1 insider sale (~$695K) is disclosed; it is unlikely to materially change ADPT’s valuation absent other catalysts.
What to watch
The article lacks context on whether this is part of a larger selling cadence, and it provides no linkage to company-specific news.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Adaptive Biotechnologies (ADPT).
Ticker impact
Adaptive Biotechnologies insider Form 4 shows Chief People Officer LO FRANCIS sold 39,741 shares for ~$695K under a 10b5-1 plan.
Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.
The disclosure is an open-market sale by an officer under a pre-arranged 10b5-1 plan, with no accompanying operational/regulatory/financial catalyst in the text.
Market effects
No clear read-across to biotech sector fundamentals from a single officer 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with periods of weaker outlook; traders may watch for follow-on sales or other insider actions.
Key entities
- issuerAdaptive Biotechnologies Corp
Subject of the SEC Form 4 insider transaction disclosure.
- insiderLO FRANCIS
Chief People Officer who sold 39,741 ADPT shares.
- trading mechanism10b5-1 plan
Pre-arranged plan indicated as the basis for the sale.
